Category: Life Sciences
United States Life Sciences
-
Insulin Pens
... CAGR of 7.2% over the analysis period 2024-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
Gensets
... 5.6% over the analysis period 2024-2030. Diesel Gensets, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. Growth ... Read More
-
Hair Transplant Services
... at a CAGR of 14.3% over the analysis period 2024-2030. Follicular Unit Extraction Procedure, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$14.3 Billion by the ... Read More
-
Personal Finance Software
... at a CAGR of 5.0% over the analysis period 2024-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by the end of ... Read More
-
Online Home Rental Services
... 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Flats Rental Services, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$40.3 Billion by ... Read More
-
Histology and Cytology
... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More
-
Home Care Services
... at a CAGR of 7.3% over the analysis period 2024-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.7 Billion by the end of ... Read More
-
Hybrid and Electric Vehicle Fuses
... Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2024-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to record a 25.2% CAGR and ... Read More
-
Nasal Splints
... CAGR of 4.1% over the analysis period 2024-2030. Intranasal Splints, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Hospitals and Outpatient Care Centers
... Trillion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.1 Trillion While China is Forecast to Grow at 7.6% CAGR The Hospitals and Outpatient ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. ... Read More
-
Operating Room Integrated Systems
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. HD Display Systems, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.2 Billion by ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Microelectronic Medical Implants
... at a CAGR of 8.0% over the analysis period 2024-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$22.7 Billion by the end ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
-
Population Health Management
... at a CAGR of 12.2% over the analysis period 2024-2030. Population Health Management Software, one of the segments analyzed in the report, is expected to record a 13.1% CAGR and reach US$61.7 Billion by the ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Probiotics Dietary Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of ... Read More
-
Nursing Education Market in US 2025-2029
... the nursing education market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the ... Read More